We are committed to patient-focused and science-driven research to discover and develop new therapies for underserved populations and markets.
Investigator Initiated Trial (IIT) describes a study initiated and conducted by a qualified research investigator or sponsor, alone or in collaboration with others, and provides direction related to the administration, dispensing, and appropriate use of drugs for research. Our IIT program supports research including non-clinical, clinical, health economics and outcomes research, and non-interventional studies (real world evidence).
If you would like to access current study information, submit protocol revisions/amendments, or submit new proposals/protocols, please visit BeiGene’s IIT Portal.